Clinical Pharmacokinetics of Low-Dose Pulse Methotrexate in Rheumatoid Arthritis
- 1 March 1996
- journal article
- research article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 30 (3) , 194-210
- https://doi.org/10.2165/00003088-199630030-00002
Abstract
Low-dose pulse methotrexate has emerged as one of the most frequently used slow-acting, symptom-modifying antirheumatic drugs in patients with rheumatoid arthritis (RA) because of its favourable...Keywords
This publication has 97 references indexed in Scilit:
- TOTAL AND FREE METHOTREXATE PHARMACOKINETICS, WITH AND WITHOUT PIROXICAM, IN RHEUMATOID ARTHRITIS PATIENTSRheumatology, 1995
- Methotrexate in Rheumatoid ArthritisDrugs, 1994
- Clinical Pharmacokinetics of Slow-Acting Antirheumatic DrugsClinical Pharmacokinetics, 1993
- The effect of food on the absorption of methotrexate sodium tablets in healthy volunteersArthritis & Rheumatism, 1992
- Effect of food on the bioavailability of low‐dose methotrexate in patients with rheumatoid arthritisArthritis & Rheumatism, 1992
- Interaction of Etretinate with Methotrexate Pharmacokinetics in Psoriatic PatientsThe Journal of Clinical Pharmacology, 1990
- Biliary elimination of low‐dose methotrexate in humansArthritis & Rheumatism, 1990
- Pharmacokinetics of Low-Dose Methotrexate in Rheumatoid Arthritis PatientsJournal of Pharmaceutical Sciences, 1989
- Pharmacokinetics of methotrexate in continuous ambulatory peritoneal dialysisInternational Journal of Clinical Pharmacy, 1988
- Clinical Pharmacokinetics of Methotrexate1Clinical Pharmacokinetics, 1978